Leavell Investment Management, Inc. Astrazeneca PLC Transaction History
Leavell Investment Management, Inc.
- $1.79 Billion
- Q2 2024
A detailed history of Leavell Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 15,760 shares of AZN stock, worth $1.23 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
15,760
Previous 14,169
11.23%
Holding current value
$1.23 Million
Previous $959,000
28.15%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.06 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.32 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.16 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.86 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...